Peer-reviewedCC BYFrontiers in cardiovascular medicine16 Oct 2026

Serum free eicosapentaenoic acid-to-arachidonic acid ratio and long-term risk of major adverse cardiovascular events in patients with coronary artery disease

Changguo Ou¹
Wenli Wang¹
Dongliang Liang²
Jiangxiong Wen²
Zhiwen Xu²
Yuli Huang³
Jianqiu Liang²
Jiandi Wu¹

¹The First Clinical Medical College of Guangdong Medical University , ,
²Department of Cardiology, Foshan Second People’s Hospital , ,
³Department of Cardiology, Eighth Affiliated Hospital of Southern Medical University , ,

A biomarker risk score predicts adverse cardiovascular outcomes in patients with angina and non-obstructive coronary artery disease
Jingwen Huang, Ana Leon, Julia Ossi +16
American journal of preventive cardiology10 Jun 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Triglyceride-glucose index and risk of major adverse cardiovascular events in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
Selda Murat, Fatih Aydin, Bektas Murat
Postepy w kardiologii interwencyjnej = Advances in interventional cardiology1 Sep 2026Peer-reviewedCC BY-NC-SAFull textEndocrinology & metabolismEurope PMCPMC
Galectin-3–enhanced prognostic models for major adverse cardiovascular events in Vietnamese patients with acute coronary syndrome: A prospective cohort study
Bao The Nguyen, Pham Van Do, Hoa Thai Nguyen +3
Science Progress18 Sep 2026Peer-reviewedCC BY-NC 4.0Full textCardiovascular medicinePMC
Prognostic value of the C-reactive protein-triglyceride-glucose index (CTI) for major adverse cardiovascular events in patients with coronary artery disease: a retrospective cohort study
Lirong Zhou, Qin Yang, Baozhen Zhu +9
BMJ Open26 Oct 2026Peer-reviewedCC BY-NC 4.0Full textCardiovascular medicineCrossrefPMC
Prognostic value of the apelin-12-to-white blood cell ratio for long-term major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective cohort study.
Xiaojun Zeng, Chongjian Zhang, Liu Yang +3
Journal of thoracic disease29 Sep 2026Peer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMC

Cite

BibTeX

@article{ou2026serum,
  title = {{Serum free eicosapentaenoic acid-to-arachidonic acid ratio and long-term risk of major adverse cardiovascular events in patients with coronary artery disease}},
  author = {Changguo Ou and Wenli Wang and Dongliang Liang and Jiangxiong Wen and Zhiwen Xu and Yuli Huang and Jianqiu Liang and Jiandi Wu},
  journal = {Frontiers in cardiovascular medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658503},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Serum free eicosapentaenoic acid-to-arachidonic acid ratio and long-term risk of major adverse cardiovascular events in patients with coronary artery disease
AU  - Changguo Ou
AU  - Wenli Wang
AU  - Dongliang Liang
AU  - Jiangxiong Wen
AU  - Zhiwen Xu
AU  - Yuli Huang
AU  - Jianqiu Liang
AU  - Jiandi Wu
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in cardiovascular medicine
UR  - https://europepmc.org/article/PMC/PMC13658503
SN  - 2297-055X
ER  -

Related

Cite